Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer

Oncogene

Volumn 24, Issue 16, 2005, Pages 2705-2714

  Wang, Wei ^a,b   Huper, Gudrun ^a   Guo, Yueqi ^a   Murphy, Susan K ^a   Olson Jr , John A ^a   Marks, Jeffrey R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast cancer; Expression array; GADD45a; Methylation

Indexed keywords

ALPHA CATENIN; AZACITIDINE; BISULFITE; DINUCLEOTIDE; DIPHTHERIA TOXIN RECEPTOR; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45A; PROTEIN KINASE FYN; RECEPTOR; TELOMERASE; TRANSCRIPTOME; UNCLASSIFIED DRUG; ZYXIN;

ARTICLE; BASE PAIRING; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL IMMORTALIZATION; CELL STRAIN MCF 7; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; GROWTH; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR GENE;

AZACITIDINE; BASE SEQUENCE; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHROMOSOME MAPPING; DNA METHYLATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR CELLS, CULTURED;

EID: 17844395749     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208464     Document Type: Article

References (50)

1. Amundson SA, Zhan Q, Penn LZ and Fornace Jr AJ. (1998). Oncogene, 17, 2149-2154.
2. Band V and Sager R. (1989). Proc. Natl. Acad. Sci. USA, 86, 1249-1253.
3. Band V, Zajchowski D, Kulesa V and Sager R. (1990). Proc. Natl. Acad. Sci. USA, 87, 463-467.
4. Baylin SB. (2004). Novart. Found. Symp., 259, 226-233.
5. Bovenzi V, Le NL, Cote S, Sinnett D, Momparler LF and Momparler RL. (1999). Anticancer Drugs, 10, 471-476.
6. Coombes MM, Briggs KL, Bone JR, dayman GL, El-Naggar AK and Dent SY. (2003). Oncogene, 22, 8902-8911.
7. Cui J, Rohr LR, Swanson G, Speights VO, Maxwell T and Brothman AR. (2001). Prostate, 46, 249-256.
8. Dairkee SH, Puett L and Hackett AJ. (1988). J. Natl. Cancer Inst., 80, 691-695.
9. Davis P, Bazar K, Huper G, Lozano G, Marks J and Iglehart JD. (1996). Oncogene, 13, 1315-1322.
10. Dobrovic A and Simpfendorfer D. (1997). Cancer Res., 57, 3347-3350.
11. Domann FE, Rice JC, Hendrix MJ and Futscher BW. (2000). Int. J. Cancer, 85, 805-810.
12. Dowell JE and Minna JD. (2004). J. Clin. Oncol., 22, 1353-1355.
13. Egger G, Liang G, Aparicio A and Jones PA. (2004). Nature, 429, 457-463.
14. Engelman JA, Zhang XL and Lisanti MP. (1999). FEBS Lett., 448, 221-230.
15. Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE and Sukumar S. (2001a). Lancet, 357, 1335-1336.
16. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J and Sukumar S. (2001b). Cancer Res., 61, 2782-2787.
17. Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S and Argani P. (2003). Int. J. Cancer, 107, 970-975.
18. Fan W, Jin S, Tong T, Zhao H, Fan F, Antinore MJ, Rajasekaran B, Wu M and Zhan Q. (2002). J. Biol. Chem., 277, 8061-8067.
19. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR and Sukumar S. (2000). Proc. Natl. Acad. Sci. USA, 97, 6049-6054.
20. Foster SA, Wong DJ, Barrett MT and Galloway DA. (1998). Mol. Cell. Biol. 18, 1793-1801.
21. Grunau C, Clark SJ and Rosenthal A. (2001). Nucleic Acids Res., 29, E65.
22. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD and Haber DA. (1999). Cell, 97, 575-586.
23. Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace Jr AJ and Zhan Q. (2000). Oncogene, 19, 4050-4057.
24. Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J and Polyak K. (2001). Proc. Natl. Acad. Sci. USA, 98, 9796-9801.
25. Li Q, Ahuja N, Burger PC and Issa JP. (1999). Oncogene, 18, 3284-3289.
26. Lin X, Liang M and Feng XH. (2000). J. Biol. Chem., 275, 36818-36822.
27. Marks J, Lin J, Miller D, Lozano G, Herbert J and Levine AJ. (1988). Prog. Clin. Biol. Res., 284, 163-186.
28. McPherson SJ, Thomas TZ, Wang H, Gurusinghe CJ and Risbridger GP. (1997). J. Endocrinol., 154, 535-545.
29. Mullan PB, Quinn JE, Gilmore PM, McWilliams S, Andrews H, Gervin C, McCabe N, McKenna S, White P, Song YH, Maheswaran S, Liu E, Haber DA, Johnston PG and Harkin DP. (2001). Oncogene, 20, 6123-6131.
30. Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E, Marth C and Widschwendter M. (2003). Cancer Res., 63, 7641-7645.
31. Murphy SK and Jirtle RL. (2001). Cancer Handbook Alison MR, Gooderham NG (eds). Nature Publishing Reference: London, pp. 317-333.
32. Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE and Futscher BW. (2003). Oncogene, 22, 3624-3634.
33. Oue N, Matsumura S, Nakayama H, Kitadai Y, Taniyama K, Matsusaki K and Yasui W. (2003). Oncology, 64, 423-429.
34. Parker BS, Cutts SM, Nudelman A, Rephaeli A, Phillips DR and Sukumar S. (2003). Cancer Biol. Ther., 2, 259-263.
35. Paz MF, Fraga MF, Avila S, Guo M, Pollan M, Herman JG and Esteller M. (2003). Cancer Res., 63, 1114-1121.
36. Pechoux C, Gudjonsson T, Ronnov-Jessen L, Bissell MJ and Petersen OW. (1999). Dev. Biol., 206, 88-99.
37. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Aksien LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D. (2000). Nature, 406, 747-752.
38. Sanjo H, Kawai T and Akira S. (1998). J. Biol. Chem., 273, 29066-29071.
39. Sirchia SM, Ferguson AT, Sironi E, Subramanyan S, Orlandi R, Sukumar S and Sacchi N. (2000). Oncogene, 19, 1556-1563.
40. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP and Borresen-Dale AL. (2001). Proc. Natl. Acad. Sci. USA, 98, 10869-10874.
41. Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD and Gazdar AF. (1998). Cancer Res., 58, 3237-3242.
42. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J and Sukumar S. (2001). Oncogene, 20, 3348-3353.
43. van Noesel MM, van BS, Voute PA, Herman JG, Pieters R and Versteeg R. (2003). Genes Chromosomes Cancer, 38, 226-233.
44. Wang W, Nahta R, Huper G and Marks JR. (2004). Mol. Cancer Res., 2, 442-452.
45. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ and Harris CC. (1999). Proc. Natl. Acad. Sci. USA, 96, 3706-3711.
46. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson Jr JA, Marks JR and Nevins JR. (2001). Proc. Natl. Acad. Sci. USA, 98, 11462-11467.
47. Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schafer R and Sers C. (2001). Am. J. Pathol., 159, 1635-1643.
48. Woodcock DM, Linsenmeyer ME, Doherty JP and Warren WD. (1999). Br. J. Cancer, 79, 251-256.
49. Zelent A, Waxman S, Carducci M, Wright J, Zweibel J and Gore SD. (2004). Clin. Cancer Res., 10, 4622-4629.
50. Zhan Q, Lord KA, Alamo Jr I, Hollander MC, Carrier F, Ron D, Kohn, KW, Hoffman B, Liebermann DA and Fornace Jr AJ. (1994). Mol. Cell. Biol., 14, 2361-2371.